It's one of many changes Bayer CEO Bill Anderson has made. Still, the company's stock price this year has struggled.
Zacks.com on MSN1mon
Bayer Q3 Earnings Miss Estimates, Nubeqa, Kerendia Boost SalesHowever, sales of oral anticoagulant Xarelto, co-developed with J&J JNJ, decreased 23% to €802 million due to competitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results